MedPath
NMPA Approval

Sodium Hyaluronate Injection

国药准字H20174089

August 5, 2024

Drug Information

玻璃酸钠注射液

注射剂

2.5ml:25mg

化学药品

August 5, 2024

Company Information

Applicant Company

上海市松江工业区洞泾路5号

Manufacturing Company

上海昊海生物科技股份有限公司,上海建华精细生物制品有限公司

上海市松江工业区洞泾路5号,上海市奉贤区沪发路858号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

玻璃酸钠注射液 - NMPA 批准文号 | MedPath